AUTOLOGOUS VS. ALLOGENEIC CELL THERAPIES
When the cells that are used for the therapy originate from the patient it is referred to as an autologous cell therapy.
When the cells that are used for the therapy originate from a donor it is referred to as an allogeneic cell therapy.
Chimeric: Media Thread, page-265
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.002(13.0%) |
Mkt cap ! $9.951M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $13.65K | 1.300M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 2625597 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 88904 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |